Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.

Saved in:
Bibliographic Details
Title: Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
Authors: Mahomed S; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Garrett N; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa., Capparelli EV; University of California, San Diego, California, USA., Osman F; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Harkoo I; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Yende-Zuma N; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Gengiah TN; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Archary D; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Samsunder N; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Baxter C; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Mkhize NN; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Modise T; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa., Carlton K; Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., McDermott A; Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Moore PL; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Karim QA; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Department of Epidemiology, Columbia University, New York, New York, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Fast PE; International AIDS Vaccine Initiative, New York, New York, USA.; Pediatric Infectious Diseases, Stanford University School of Medicine, Palo Alto, California, USA., Mascola JR; Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ledgerwood JE; Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Morris L; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Abdool Karim SS; CAPRISA, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Department of Epidemiology, Columbia University, New York, New York, USA.
Source: The Journal of infectious diseases [J Infect Dis] 2022 Aug 26; Vol. 226 (3), pp. 510-520.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6613
DOI:10.1093/infdis/jiac041